This inventor holds 2 USPTO granted patents. Top assignees: Abbott Healthcare Products B.v., Abbvie Bahamas Limited. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Agatha A M Rensink: Innovator in Pharmaceutical Chemistry
Introduction
Agatha A M Rensink is a notable inventor based in Weesp, Netherlands. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various neurological and psychological disorders. With a total of two patents to her name, her work has the potential to impact the treatment of numerous conditions.
Latest Patents
Rensink's latest patents focus on arylsulfonyl pyrazoline carboxamidine derivatives, which serve as antagonists of 5-HT6 receptors. These inventions detail methods for the preparation of these compounds and introduce novel intermediates useful for their synthesis. The applications of these compounds are extensive, particularly in treating conditions such as Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, and various other mood and cognitive disorders. The compounds are designed to provide therapeutic effects for patients suffering from a wide range of ailments, including but not limited to, Alzheimer's disease, obesity, and type-2 diabetes.
Career Highlights
Throughout her career, Agatha A M Rensink has worked with prominent companies in the pharmaceutical industry, including AbbVie Bahamas Limited and Abbott Healthcare Products B.V. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in drug development.
Collaborations
Rensink has collaborated with notable colleagues such as Arnold Van Loevezijn and Wouter I Iwema Bakker. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.
Conclusion
Agatha A M Rensink is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform the treatment landscape for various neurological and psychological disorders. Her contributions through her patents reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile